Dexcom Sustainability Profile
Dexcom, Inc., a leading player in the diabetes care industry, is headquartered in the United States. Founded in 1999, the company has pioneered continuous glucose monitoring (CGM) technology, significantly enhancing diabetes management for patients worldwide. With a strong presence in North America, Europe, and Asia, Dexcom focuses on developing innovative solutions that empower individuals to take control of their health. The company's flagship products, including the Dexcom G6 and G7 CGM systems, offer real-time glucose monitoring with exceptional accuracy and ease of use. These devices are distinguished by their ability to provide users with actionable insights, helping to prevent hypoglycaemic events and improve overall glycaemic control. Dexcom's commitment to innovation has solidified its position as a market leader, recognised for its contributions to diabetes management and patient care.
DitchCarbon Score
How does Dexcom's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dexcom's score of 40 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dexcom's reported carbon emissions
In 2023, Dexcom, Inc. reported total carbon emissions of approximately 479,576,000 kg CO2e. This figure encompasses emissions across all scopes, with Scope 1 emissions at about 6,652,000 kg CO2e, Scope 2 emissions at approximately 25,291,000 kg CO2e, and Scope 3 emissions constituting the majority at around 479,576,000 kg CO2e. Dexcom's emissions data reflects a commitment to transparency, as it has disclosed emissions across all three scopes. The company has not set specific reduction targets under the Science Based Targets initiative (SBTi) as of the latest updates, with previous commitments now expired. However, it remains committed to near-term targets, indicating ongoing efforts to address its carbon footprint. The company operates within the healthcare equipment and supplies sector and is headquartered in the United States. While no net-zero commitment has been established, Dexcom continues to engage in sustainability practices aimed at reducing its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 2,044,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 9,371,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 1,257,000 | 0,000,000 | 0,000,000 | 000,000,000 |
How Carbon Intensive is Dexcom's Industry?
How Carbon Intensive is Dexcom's Location?
Dexcom's Scope 3 Categories Breakdown
Dexcom's Scope 3 emissions, which increased significantly last year and increased significantly since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 68% of Scope 3 emissions.
Top Scope 3 Categories
Dexcom's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dexcom has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Insulet
Senseonics Holdings, Inc.
Frequently Asked Questions
Common questions about Dexcom's sustainability data and climate commitments